Abstract 5512: Combining RAS(ON) G12C-selective and RAS(ON) multi-selective inhibitors overcomes sotorasib resistance driven byKRASG12C amplification or NRASG13R mutation
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Moffitt Cancer Center, Revolution Medicines (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409634038
